(2R)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-nitrosomorpholine

(2R)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-nitrosomorpholine is a chemical compound that belongs to the class of morpholine derivatives. It is primarily used in medicinal chemistry as a potential anticancer drug due to its ability to target specific cancer cells and inhibit their growth. The chemical structure of (2R)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-nitrosomorpholine consists of a morpholine ring that is substituted with a nitroso group, a fluorophenyl group, and a (R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy group. This compound is a chiral molecule, which means it exists in two enantiomeric forms (R)- and (S)-. The (R)-enantiomer of (2R)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-nitrosomorpholine is the biologically active form and demonstrates better pharmacological properties than the (S)-enantiomer. In terms of usage, (2R)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-nitrosomorpholine is primarily used in preclinical studies to evaluate its anticancer potential. It works by inhibiting the growth of cancer cells and inducing apoptosis (programmed cell death). Overall, (2R)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-nitrosomorpholine is a promising compound in the field of medicinal chemistry, with potential applications in cancer therapy.